Singapore markets open in 2 hours 59 minutes
Straits Times Index
3,332.80 -10.55 (-0.32%) S&P 500
5,460.48 -22.39 (-0.41%) Dow
39,118.86 -45.24 (-0.12%) Nasdaq
17,732.60 -126.10 (-0.71%) Bitcoin USD
61,839.57 +901.62 (+1.48%) CMC Crypto 200
1,287.30 +3.47 (+0.27%)
BioXcel Therapeutics, Inc. (BTAI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 48.04M |
| Enterprise value | 75.88M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 21.64 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 43.21 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.36 |
| 52-week change 3 | -83.76% |
| S&P500 52-week change 3 | 22.55% |
| 52-week high 3 | 12.4000 |
| 52-week low 3 | 1.1100 |
| 50-day moving average 3 | 1.9361 |
| 200-day moving average 3 | 2.8564 |
Share statistics
| Avg vol (3-month) 3 | 581.73k |
| Avg vol (10-day) 3 | 946.45k |
| Shares outstanding 5 | 37.53M |
| Implied shares outstanding 6 | 37.53M |
| Float 8 | 25.81M |
| % held by insiders 1 | 21.77% |
| % held by institutions 1 | 34.18% |
| Shares short (14 Jun 2024) 4 | 1.49M |
| Short ratio (14 Jun 2024) 4 | 2.48 |
| Short % of float (14 Jun 2024) 4 | 5.23% |
| Short % of shares outstanding (14 Jun 2024) 4 | 3.97% |
| Shares short (prior month 15 May 2024) 4 | 1.63M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -4,151.72% |
Management effectiveness
| Return on assets (ttm) | -66.96% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 1.76M |
| Revenue per share (ttm) | 0.06 |
| Quarterly revenue growth (yoy) | 182.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -140.27M |
| Net income avi to common (ttm) | -153.05M |
| Diluted EPS (ttm) | -5.1800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 74.14M |
| Total cash per share (mrq) | 1.98 |
| Total debt (mrq) | 102.34M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.57 |
| Book value per share (mrq) | -2.15 |
Cash flow statement
| Operating cash flow (ttm) | -120.36M |
| Levered free cash flow (ttm) | -70.12M |
© 2024 Yahoo. All rights reserved.